Skip to content
Search

Latest Stories

Omnicell appoints new community pharmacy division leader

Omnicell appoints new community pharmacy division leader

Dedicated specialist teams developed to better deliver on the needs of community pharmacists 

American healthcare technology company Omnicell has appointed Edward Platt as the new Senior Commercial Director of its UK community pharmacy division.


Along with this new role, Edward, who joined Omnicell in 2015, will continue his current leadership remit for Omnicell’s UK & Ireland hospital division.

He will be leading a revamped commercial team, which would be responsible for increasing Omnicell’s footprint of automation and consumable solutions delivered into UK community pharmacies.

As part of the revamp, the company has created dedicated specialist teams to ensure the needs and challenges of community pharmacists (small independents and small multiple operators) can be fully understood and supported.

Edward said: “Faced with funding cuts, staff shortages, rising costs, increased demand and the continuing growth of mail-order pharmacies, community pharmacists are facing a myriad of challenges just to survive.

“Community pharmacies need to make tangible change to their operating models, and we see the adoption of automation as key in helping them evolve into sustainable and successful businesses. With our new and repurposed team, we are fully committed to supporting community pharmacists and helping them to realise the benefits of harnessing technology,” he added.

Kath Hughes, who has 25 years of experience in supplying solutions into the healthcare sector, has been appointed as Senior National Sales Manager, and she will be managing Omnicell’s national chains and buying group relationships.

Tariq Hussain, who brings more than 20 years of experience in supplying pharmacy automation and pharmaceuticals to community pharmacy, will be responsible for the company’s major multiple operators as National Strategic Account Manager.

Additionally, three new Regional Sales Managers have been appointed to ­­­­­­­­support the needs of more than 400 small multiple pharmacy businesses, and two people to focus on supporting the needs of small independent pharmacies.

Omnicell is a leading provider of medication management solutions and adherence tools for health systems and pharmacies.  They company recently managed the 200th UK installation of their market-leading Pharmaself24 prescription collection kiosk.

More For You

PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less